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To identify cell surface molecules that define position in the 
mammalian nervous system, we previously characterized 
the binding of two monoclonal antibodies, ROCAl and 
ROCAP, to adult rat sympathetic ganglia and intercostal 
nerves. The binding of ROCAl is highest in rostra1 ganglia 
and nerves and declines in a graded manner in the caudal 
segments. ROCAP labels the same cells in ganglia and nerves 
as ROCAl, but not in a position-selective manner. We now 
show by immunoblot analysis that ROCAl recognizes two 
antigens in membranelcytoskeletal fractions of peripheral 
nerves and ganglia: (1) a Triton X-lOO-insoluble, 60 kDa 
protein and (2) a Triton X-lOO-soluble, 26 kDa protein. The 
60 kDa protein is expressed at higher levels in rostra1 than 
in caudal intercostal nerves, and is identified as the inter- 
mediate filament protein peripherin. In contrast, it is the 
ROCAl epitope on the 26 kDa protein, and not the protein 
itself, that is preferentially visualized immunohistochemi- 
tally in rostra1 nerves and ganglia. We suggest that the 
ROCAl epitope on the 26 kDa protein is masked in sections 
of caudal nerves and ganglia. Amino acid sequence data 
obtained from the affinity-purified 26 kDa protein indicate 
significant homology with human CD9, a cell surface protein 
implicated in intercellular signaling in hematopoietic cells. 
These results suggest that intermediate filament gene ex- 
pression and epitope masking on the cell surface may be 
involved in functions related to position in the nervous sys- 
tem. 
[Key words: rostrocaudal position, gradients, epitope 
masking, intermediate filaments, peripherin, CD91 
It is thought that positional information at the cellular level 
plays a key role in pattern formation (Wolpert, 1989). The mo- 
lecular mechanisms underlying the specification of positional 
information have been studied in Drosophila and mice. Home- 
otic selector gene expression, for instance, specifies segmental 
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differences in Drosophila embryos (Lewis, 1963, 1978; Nusslein- 
Volhard and Wieschaus, 1980), and is restricted to particular 
domains along the anterior-posterior axis of the mouse embryo 
in the brain and spinal cord, and in many mesoderm-derived 
tissues (Holland and Hogan, 1988; Kessel and Gruss, 1990; 
McGinnis and Krumlauf, 1992). The anterior-posterior ex- 
pression boundaries of these genes correlate with their relative 
3’-5’ positions on the chromosomes ofboth Drosophila and mice 
(Akam, 1989; Duboule and Dolle, 1989; Graham et al., 1989). 
Molecular analyses have shown that the transcription factors 
cncodcd by many of these genes regulate the specification of 
positional information by an array of hierarchical and combi- 
natorial interactions (Ingham, 1988). Mutations in the homeotic 
genes affect regional specification in both Drosophila and mice 
(Nusslein-Volhard and Wieschaus, 1980; Chisaka and Capecchi, 
1991; Mouellic et al., 1992), and can lead to alterations in the 
pathways ofaxonal growth (Doe et al., 1988; Lufkin et al., 1991; 
Chisaka et al., 1992). The latter results suggest hat the spcci- 
fication of neuronal connections may be based, in part, on the 
downstream products of the homeotic genes. 
While these genes regulate segmental identity, they encode 
DNA-binding proteins localized to the cell nucleus, and thus 
are not able to convey positional information directly to neigh- 
boring cells. It seems likely that these positional regulators ac- 
tivate target genes in a cascade, leading to the expression of 
particular cell surface and secreted proteins that influence in- 
tercellular interactions. The identification ofdownstrcam targets 
of homcotic gene control has only recently begun (Gould et al., 
1990; Immergluck et al., 1990; Reuter et al., 1990; St. Johnston 
et al., 1990). The neural cell adhesion molecule (NCAM) has a 
homeodomain binding site in its promoter region (Hirsch et al., 
1991), and HOX 2.5 and 2.4 can modulate transcription from 
this promoter (Jones et al., 1992). 
Additional candidates for surface molecules that may supply 
positional information in the vertebrate nervous system are 
those whose distribution reflects particular patterns of synaptic 
connections. Considerable attention has focused on the reti- 
notectal system, where Sperry’s chemoaffinity hypothesis pos- 
tulates that the specificity of connections is established through 
matching biochemical differences among cells in the retina with 
corresponding differences among cells in the tectum (Sperry, 
1963). A number of cell surface proteins display intriguing pat- 
terns of expression in this regard. TRAP (temporal retinal axon 
protein) is asymmetrically distributed in the nasal-temporal axis 
of the retina (McLoon, 199 l), the TOP,, and TOP,, proteins 
arc distributed in dorsoventral and anteroposterior topographic 
gradients in both retina and tectum (Trisler, 1990), and a 33 
kDa membrane glycoprotein is enriched in the posterior tectum 
(Stahl et al., 1990). Moreover, an antiserum raised against pos- 
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terior membranes that recognizes the 33 kDa protein abolishes 
both the ability of these membranes to collapse retina1 growth 
cones and to specifically inhibit temporal retinal axon growth 
(Stahl et al., 1990). Thus, this protein may be responsible for 
the preferential growth of temporal retina1 axons on anterior 
membranes, through its ability to specifically inhibit or repulse 
temporal growth cones (Walter et al., 1987, 1990; Muller et al., 
1990). In addition, an isoform ofaldehyde dehydrogenase (AHD- 
2) is present at much higher levels in the dorsal as compared to 
the ventral retina (McCaffery et al., 1991). Since AHD-2 oxi- 
dizes retinaldehyde to retinoic acid (Lee et al., 199 I), and recent 
results have demonstrated asymmetrical rctinoic acid synthesis 
along the dorsovcntral axis ofthc retina (McCaffery et al., 1992), 
it seems possible that retinoic acid plays a role in the specili- 
cation of positional information in this system. 
Cell surface epitopes are asymmetrically distributed within 
the retinotectal system, as well. For example, the JONES car- 
bohydrate cpitope present on several gangliosides (Schlosshauer 
et al., 1988) is distributed in a strong dorsoventral gradient in 
the developing retina (Constantine-Paton et al., 1986; Rcin- 
hardt-Maelickc et al., 1990). Multiple monoclonal antibodies 
(mAbs) specific for a 43 kDa protein involved in protein trans- 
lation identify a dorsoventral asymmetry in the embryonic ret- 
ina (McCaffery et al., 1990; Rabacchi et al., 1990). Despite the 
pronounced immunohistochemical gradient displayed by the 
binding of these mAbs, however, the 43 kDa protein itself is 
not asymmetrically distributed. Rather, the differential binding 
appears to be due to a difference in conformation or accessibility; 
the 43 kDa protein is more labile to protcolysis in the dorsal 
retina, and the epitopes in the ventral retina can be exposed by 
an appropriate fixation protocol (McCaffery et al., 1990; Ra- 
bacchi et al., 1990). 
The connections between preganglionic neurons in the spinal 
cord and postganglionic sympathetic neurons also form a highly 
stereotyped pattern, with a rostrocaudal gradient of specificity 
(Langley, 1892, 1895; Purves and Lichtman, 1978). Moreover, 
transplantation experiments in this system suggest that neurons 
and muscles may share cell surface molecules that define ros- 
trocaudal position (Purves et al., 198 1; Wigston and Sanes, 1982, 
1985). Two experimental paradigms have identified molecules 
that are of interest in this regard. A > lOO-fold rostrocaudal 
gradient of CAT levels is detected in muscles of adult mice 
bearing a myosin light chain I (MLCl)-CAT transgenc (Don- 
oghue et al., 199 1). In these mice, muscle rostrocaudal position 
determines the level of CAT that it expresses, with caudal mus- 
cles expressing the highest levels. Since there is no gradient of 
endogenous MLCl expression, it is suggested that the MLCl 
gene contains elements responsive to a positionally graded signal 
that is masked or normally inactive (Donoghue et al., 1991). 
This notion is consistent with the existence of endogenous reg- 
ulators of position in targets of spinal motor neurons. 
Other potential candidates for the specification of positional 
information in this system have been identified through a mAb 
approach. Immunohistochemical staining with one of these 
mAbs, ROCAI (ROstroCAudal), is highest in rostra1 sympa- 
thetic ganglia and intercostal nerves, and declines in a graded 
manner in the caudal segments (Suzuc ct al., 1990). The ROCAl 
antigen was identified as a 65 kDa protein that is enriched in 
rostra1 intercostal nerves (Suzue et al., 1990) and, based on its 
distribution, is a potential downstream product of the homeotic 
selector genes (Suzue et al., 1990). We here identify this antigen 
as a cytoskeletal component, and present evidence that ROCA I 
binds a 26 kDa surface membrane protein as well. Surprisingly, 
this surface protein is also recognized by another mAb, ROCAZ, 
that does not define rostrocaudal gradients. This indicates that 
it is the ROCAI epitope on the 26 kDa protein, and not the 
protein itself, that is preferentially visualized immunohisto- 
chemically in rostra1 nerves and ganglia. Thus, the ROCAl 
epitopc itself appears to bc a key indicator of position, as it 
defines rostrocaudal gradients associated with two different pro- 
teins. 
Materials and Methods 
Antibodies 
KOCAl and ROCAZ are both lgG2b mouse mAbs. The production 
and initial characterization of these antibodies have been previously 
described (Suzue at al., 1990). The ROCAI and KOCAZ hybridomas 
have been repeatedly subcloned. Each ROCA I subclone recognizes both 
the 60 kDa (peripherin) and the 26 kDa (rat CD9 homolog) proteins, 
while every ROCAZ subclone is specific for the 26 kDa protein. Large 
amounts of purified ROCAI antibody were obtained from hybridoma 
supematant through the use of the mAb Trap-G kit (Pharmacia). The 
anti-peripherin antiserum (199-2) was produced in a rabbit as previously 
described (Brody et al., 1989). Anti-MBP is an IgG I mouse mAb specific 
for myelin basic protein (Boehringer Mannheim). Anti-NF-M is an IgG I 
mouse mAb (clone NN 18) specific for intermediate-size neurolilaments 
(I 60 kDa) (Sigma Immunochemicals). 
Protein preparations 
Mcmbrane/cytoskeletaI fractions. Tissues were immediately dissected 
from rats killed by asphyxiation with carbon dioxide, and immediately 
froxen on dry ice. Upon thawing, tissues were homogenized either by 
hand or by a Polytron (Brinkman Instruments Co.) in homogenization 
buffer (50 mM Tris-HCI (pH 7.4), 50 mM NaCI, 5 mM EDTA, 2 mM 
EGTA) containing five protease inhibitors: I mM phenylmethylsulfonyl 
lluoride, 20 rg/ml aprotinin, 20 &ml turkey egg white trypsin inhibitor, 
2 mM benzamidine, and 5 mM N-ethylmaleimide. The homogenates 
were first centrifuged at 1000 rpm for 10 min in an IEC HN-SII tablctop 
centrifuge lo pellet nuclei and cell debris. The resulting supematants 
were next centrifuged at 6000 x g for I5 min in a Sorvall SS 34 rotor 
to remove mitochondria and any remaining cell debris. The supema- 
tants were centrifuged at 100,000 x g for 1 hr in a Beckman 70 Ti rotor. 
The pellets were resuspended in homogenization buffer and washed 
twice by centrifugation at 100,000 x g for 1 hr and subsequent resus- 
pension. The final pellets were resuspended in homogenization buffer. 
This material, which will be referred to as the mcmbrane/cytoskeletaI 
fraction. was cithcr used immediately or frozen at -80°C: until further 
USC. All procedures were carried out at 4°C. Protein concentration was 
determined by the method of Lowry et al. (195 I). 
Triton X- lOO-soluble and -inwluble fractions. Membrane/cytoskel- 
ctal fractions were rccentrifuged at 100,000 x g for 1 hr in a Beckman 
70 Ti rotor. The pellets were thoroughly resuspended by homogenization 
in homogenization buffer containing 1% Triton X-100, and again cen- 
trifugcd at 100,000 x g for I hr. The resulting supernatants are referred 
lo as the Triton X- 1 OO-soluble fractions, and the pellets, resuspended 
in homogenization buffer without detergent, arc referred to as the Triton 
X-IOO-insoluble fractions. Essentially all of the 26 kDa protein (rat 
CD9 homolog) and none of the 60 kDa protein (peripherin) is solubilized 
by this procedure. The same result is obtained if NP-40 is used in place 
of Triton X- 100. 
Fusion protein. The peripherin fusion protein obtained from L. Par- 
ysek (U. Cincinnati) was generated from a nearly full-length peripherin 
cDNA insert containing coding sequence for all but the N-terminal 21 
amino acids (56 kDa; Leonard et al., I988), plus a portion of the Es&- 
erichiu coli trpE open reading frame (37 kDa), using the PATH vector 
system (Gorham et al., 1990). The extraction of the hybrid protein was 
performed as described in Koemer et al. (199 I). 
Immunoprecipitution 
Triton X- 1 00-solubilized fractions ofadult rat sciatic nerves were mixed 
(I: I) with ROCAI hybridoma supematant and rotated end-over-end 
for 12-l 6 hr at 4°C. After this incubation, 50 ~1 of Protein G-Sepharose 
beads (Sigma) wcrc added to the mixture and the incubation was con- 
tinucd for another 3 hr at room temperature. The beads were then 
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centrifuged in a microfuge, the supematant was removed, and the beads 
were washed three times in Tris-buflered saline (TBS: 0.9% NaCI. 20 
mM Tris-HCl, pH 7.4) containing 0.5% Tween-20 by a series of resus- 
pensions and centrifugations. After a linal wash in TBS without deter- 
gent, the beads were placed in 1 x nonreducing sample bufler (see below) 
for 5 min to elute bound antigens. 
AJinity purification 
Adult rat peripheral nerve (including sciatic nerve and brachial plexus) 
membrane/cytoskeletaI fractions derived from about 5-l 0 gm of nerves 
were solubilized with I% NP-40. These extracts were then frozen, thawed, 
clarified by centrifugation at 100,000 x I: for 1 hr in a Beckman 70 Ti 
rotor, and diluted to 0.5% NP-40. This preparation was then incubated 
end-over-end for 12-16 hr at 4°C with Protein G-Sepharosc beads, to 
which 6 mg/ml of purified ROCAI mAb had been coupled and cross- 
linked with 50 mM dimethyl pimelimidate (Pierce) according to Schnei- 
der et al. (1982). After the incubation, the beads wcrt‘ placed in a small 
column, washed with live column volumes of homogenization bulTer 
containing 0.5% NP-40, and linally washed with 1 column volume of 
homogenization buffer without detergent. The antigen(s) was eluted with 
2 column volumes (in 0.2 column volume fractions) of 0. I h4 glycinc- 
HCI (pH 2.7) containing 0.5% NP-40. Fractions were neutralized im- 
mediately with I M Tris-HCI (pH 9.0) (60 ~1 per 1 ml fraction). Fractions 
containing the 26 kDa protein were identified by silver staining or 
immunoblot analysis of proteins separated by SDS-PAGE. 
Electrophoresis 
O~dimensionul. SDS-PAGE was performed as described by Laemmli 
(I 970) in I .5-mm-thick, 10% polyacrylamide slab gels. All samples were 
diluted I: I with 2 x nonreducing sample buffer 120% glycerol, 4Yo SDS, 
0. I3 M Tris, 0.01 mg/ml bromophenol blue (pH 6.8)] prior to loading. 
Two-dimensionul. Two-dimensional gel electrophoresis was per- 
formed according to O’Farrell (I 975). The lirst (horizontal) dimension 
isoelectric focusing gels were run in a Mighty Small II (SE 250) apparatus 
using 0.75-mm-diameter tube gels, with 0.2% ampholines (pH 4.5-5.4; 
Pharmalyte, Sigma), according to the instructions provided by the man- 
ufacturer (Hoeffer Scientific Instruments). The proteins in the tube gels 
were further resolved in the second (vertical) dimension by SDS-PAGE 
(Laemmli, 1970), on I.5 mm, 10% polyacrylamidc slab gels. 
Pro&in staining. For detection of proteins by Coomassie blue, one- 
and two-dimensional gels were incubated in 0. I% Coomassie blue R-250, 
50% methanol, and 1 O%glacial acetic acid for 2 hr at room temperature. 
The gels were destained over 2-4 hr with multiple changes ofa solution 
containing 5% methanol and 10% glacial acetic acid. For detection of 
proteins by silver staining, a protocol similar to the one described in 
Oakley et al. (I 980) was employed. One- and two-dimensional gels were 
lixed in 50% methanol, 10% glacial acetic acid for 30 min; rinsed twice 
in 10% ethanol, 5% glacial acetic acid for 10 min each and once in 
distilled water(dH,O) for IO min; sensitized for 30 min in 0.2 M NaHCO, 
containing 1% glutaraldehyde; rinsed twice in dH,O for 10 min each; 
stained for I hr in 0.2% silver nitrate, 0.075% sodium hydroxide, 0.42Oh 
ammonium hydroxide; and developed by treatment with 0.005% citric 
acid, 0.009% formaldehyde for 5-l 0 min. The reaction was terminated 
by rinsing the gels in multiple changes of dH,O over I hr. All steps 
described above were carried out with mild agitation. Gels were dried 
using a Bio-Rad slab gel dryer (model 583). 
Immunoblotting 
Following SDS-PAGE, one- and two-dimensional gels were equilibrated 
for 15 min in transfer buffer [ 12.5 mM Tris, 96 mM glycine (pH 8.5), 
20% methanol], and the proteins within the gels were transferred to 
nitrocellulose (0.45 pm, BA85, Schleicher and Schuell) for 12-l 6 hr at 
60 V in a Mighty Small Transphor unit (Hoeffer Scientific Instruments, 
TE 22). After transfer, the nitroccllulosc was incubated in 0.5% Ponceau-S 
(solid, Sigma) and 1% glacial acetic acid for 5 min, to visualize the 
transferred proteins. Destaining of the nitroccllulose was carried out 
over I5 min with multiple changes of TBS containing 0.05% Tween- 
20 (TBST). The nitrocellulose was then blocked in TBS containing 5% 
nonfat dry milk (Carnation) for 30 min at room temperature, followed 
by three washes over I5 min in TBST. Incubation of individual nitro- 
ckllulose strips was for either 3 hr at room temperature or 12-16 hr at 
4°C. with the followinp. antibodies: ROCAI and ROCAZ (undiluted 
hybiidoma supematanis), or anti-NF-M (1:2000), anti-MBP (1:500), 
and anti-periphcrin antisera (I :2000), each diluted in TBS containing 
5% dry milk. The nitroccllulose filters wcrc then washed three times 
over I5 min in TBST. and those reacted with ROCAI. ROCAZ. anti- 
MBP, or anti-NF-M were incubated with goat anti-m&x al&y-pu- 
rilied antisera conjugated to pcroxidase (Chcmicon, Int.) diluted I:500 
in TBS containing 5% nonfat dry milk for I hr at room temperature. 
The filters reacted with the anti-periphcrin antiserum were incubated 
with goat anti-rabbit affinity-purified antisera conjugated to peroxidasc 
(Bochringer Mannheim) diluted I:500 in TBS containing 5% nonfat dry 
milk for I hr at room temperature. After this tinal incubation, the strips 
were washed twice in TBST over I5 min and then once in TBS for 5 
min. lmmunoreactivity was developed with 0.5 mg/ml 4-chloro-l- 
naphthol in 0.02% hydrogen peroxide for 2-l 5 min at room tempcra- 
turc. The reaction was terminated with multiple washes in dH,O. After 
air drying, the nitrocellulose lilters were subjected to densitometric scan- 
ning using an Ultroscan XL (LKB). 
In Figure 7b. the plots generated from densitometric scanning include 
data from two fewer immunoblots than the ones in Figure 7~. In these 
two immunoblots, the NF-M:MBP ratio was significantly less than one. 
Since in 10 other blots the NF-M:MBP ratio was quite close to one, we 
did not consider thcsc two results to bc representative, and hcncc elim- 
inated this data from the analysis. 
N-terminul amino acid sequence determinution 
About 2-5 pg of ROCA I -alTinity-purified peripheral nerve proteins were 
subjected to SDS-PAGE and transferred to ai Immobilon-P membrane 
(PVDF. 0.45 urn. Millinore). usinr the conditions described for transfer 
io nitrocellul&c. The fi’lter ‘ias then rinsed in dH,O for 5 min, stained 
with 0.1% Coomassie blue R-250 in 50% methanol (HPLC grade, Bur- 
dick and Jackson), 10% glacial acetic acid (aldchyde free, Baker) for 5 
min. and then destained in 5OYo methanol (HPLC grade), 10% glacial 
acetic acid (aldehyde free) for 5-10 min at room temperature. After a 
final rinse in dH,O for 5-10 min. a small piece of membrane containing 
only the 26 kDa band was excised, air dried, and stored at -80°C. The 
N-terminus of the 26 kDa protein was directly sequenced using a gas- 
phase microsequcnccr at the Protein Sequencing Core Facility, Beckman 
Rcscarch Institute of the City of Hope (Duartc, CA). 
Internal amino acid sequence determination 
For the 60 kDa protein, the isolated protein spot was excised from 52 
Ponceau-Sstained nitroccllulose transfers of Triton X-IOO-insoluble 
adult rat peripheral nerve proteins that had been separated in two di- 
mensions. The pooled nitroccllulose pieces (containing auproximatelv 
5 rg of protein) were incubated with i Fg ofirypsin (scqu&ing grade; 
Bochrinacr Mannheim) in 100 mM NH..HCO, for 16 hr at 37°C. The 
rcsultingpcptide fragments were separated by h’igh pressure liquid chro- 
matography, and non-trypsin peaks were subjected to microsequencing. 
The details of this procedure wcrc exactly as described by Tempst et 
al. (I 990). The pcptide sequencing was performed by the Caltech Lab- 
oratory of Macromolecular Structure Analysis. For the 26 kDa protein. 
about IO pg of the ROCA I -affinity-purified peripheral nerve proteins 
were subjected to SDS-PAGE and transferred to nitrocellulose. After 
staining with Ponceau-S, to visualize the 26 kDa band, the nitrocellulose 
was briefly destained with dH,O. The 26 kDa band was then excised 
and digested with I pg of trypsin (sequencing grade, Boehringer Mann- 
heim) in 100 mM NH,HCO, for I6 hr at 37°C. The remaining steps 
were identical to those outlined above and described in detail in Tempst 
ct al. (1990). In this case, the microsequencing was performed by the 
Protein Sequencing Core Facility, Beckman Research Institute of the 
City of Hope (Duarte. CA). 
Immunohistochemistry 
Tissues dissected from freshly killed adult or postnatal rats were em- 
bedded in Tissue-Tek O.C.T. compound (Miles), and frozen on dry ice. 
Ten micrometer sections were cut using a Bright cryostat (Hacker In- 
struments, Inc.), placed on gelatin-coated slides, and allowed to air dry 
for 2 hr. For ROCAI labeling, the sections were washed in phosphate- 
bufFercd saline (PBS: 0.9% NaCI, 0.1 M Na,HPO,, pH 7.4) three times 
over 15 min, incubated in blocking buffer (PBS containing 3% rat and 
3Yo goat serum) for 20 min. incubated in ROCAI hybridoma supcr- 
natant for 45 min. washed in blocking buffer three times over I5 min, 
incubated with fluorescein isothiocyanate (FITC)-conjugated goat anti- 
mouse IgG secondary antibody (Hi-F. Antibodies, Inc.) diluted I:200 
in blocking buffer, for 45 min, and washed in blocking buffer three times 
over 15 min. For periphcrin labeling, sections were washed in PBS three 
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Figure 1. Identification of the ROCAl and ROCA2 antigens. Mem- 
brane&ytoskeletal fractions of adult rat sciatic nerves were prepared by 
homogenization and differential centrifugation and extracted with 1% 
Triton X-100. After an additional centrifugation, the pellet and super- 
natants were subjected to SDS-PAGE and immunoblot analysis as de- 
scribed in Materials and Methods. a shows the binding of ROCAl 
hybridoma supematant to a 60 kDa protein in the detergent-insoluble 
fraction (pell.), and a 26 kDa protein in the detergent-soluble fraction 
(sup.). b shows the binding of ROCA2 hybridoma supematant to a 26 
kDa protein in the detergent-soluble fraction (sup.). Primary antibody 
binding was visualized with a peroxidase-conjugated goat anti-mouse 
IgG secondary antibody. Approximately 40 pg of protein was loaded in 
each lane. 
times over 15 min and then sequentially incubated in ice-cold methanol 
for 10 min, followed by PBS for 5 min, blocking buffer for 20 min, and 
the anti-peripherin antiserum (199-2) diluted 1:400 in blocking buffer, 
for 45 min. Sections were then washed in blocking buffer three times 
over 15 min, incubated with FITC-conjugated goat anti-rabbit IgG sec- 
ondary antibody (TAGO) diluted 1: 100 in blocking buffer, for 45 min, 
and washed in blocking buffer three times over 15 min. For the double 
labeling ofadult dorsal root ganglion (DRG) sections, the first incubation 
was with ROCAl hybridoma supematant for 1 hr, followed by a wash 
in PBS for 10 min, an incubation in FITC-conjugated goat anti-mouse 
IgG secondary antibody (Hi-F) diluted 1:lOO in PBS for 1 hr, and a 
wash in PBS for 10 min. Sections were then fixed in ice-cold methanol 
for 10 min, and washed in PBS for 10 min, and incubated in the anti- 
peripherin antiserum (199-2) diluted 1:500 in PBS for 1 hr. This was 
followed by a wash in PBS for 10 min, an incubation in Texas red- 
conjugated goat anti-mouse IgG secondary antibody (Vector Labs) di- 
luted 1: 100 in PBS, for 1 hr, and a wash in PBS for 10 min. All pro- 
cedures were carried out at room temperature. In all cases, after the 
final washing step the slides were mounted in p-phenylenediamine (Sig- 
ma), and examined in a Zeiss (ICM 405) inverted fluorescence micro- 
scope. Micrographs were generated using Tri-X Pan film. 
Results 
Identification of the ROCAI and ROCAZ antigens 
We previously identified the ROCAl antigen as a 65 kDa pro- 
tein enriched in membrane/cytoskeletal fractions derived from 
adult sympathetic ganglia and intercostal nerves (Suzue et al., 
1990). A more extensive analysis of the mobility of this protein 
on SDS-PAGE, through the use of marker proteins with similar 
molecular weights, indicates that the more accurate size is 60 
kDa (data not shown). To characterize the potential membrane 
association of this protein, we extracted membrane/cytoskeletal 
32kD- 
27 - 
-26 kD 
Figure 2. ROCA 1 and ROCAZ bind the same 26 kDa protein. Proteins 
specifically immunoprecipitated (see Materials and Methods) from adult 
rat sciatic nerves with ROCA 1, were subjected to SDS-PAGE and trans- 
ferred to nitrocellulose. The nitrocellulose transfer was incubated with 
ROCAZ hybridoma supematant. The right lane shows the binding of 
ROCA2 to the major 26 kDa protein precipitated by ROCAl. A second, 
minor band migrating at approximately 28 kDa is also precipitated and 
positively stained. This band appears to be a glycosylated form of the 
26 kDa protein, as it is indistinguishable from the 26 kDa band after 
treatment with ENDO-F (data not shown). The left lane shows the 
binding of ROCAZ to a detergent extract of adult rat sciatic nerves. 
Primary antibody binding was visualized with a peroxidase-conjugated 
goat anti-mouse IgG secondary antibody. 
preparations of adult rat sciatic nerves with 1% Triton X- 100, 
and performed immunoblots on the detergent-soluble and -in- 
soluble fractions. The 60 kDa protein is only detectable in the 
Triton X-1004nsoluble pellet, suggesting that it is not an in- 
tegral membrane protein, but instead may be a cytoskeletal or 
extracellular matrix component (Fig. la). In addition, ROCAl 
also specifically binds a 26 kDa protein that is present exclu- 
sively in the detergent-soluble fraction (Fig. la). The 60 kDa 
and 26 kDa proteins are not labeled when ROCAl is omitted 
from the incubation, nor are they labeled by a variety of other 
mAbs from the ROCA fusion protocol (data not shown). Thus, 
it is very likely that the 60 and 26 kDa proteins, which reside 
in distinct subcellular fractions, share the ROCAl epitope. 
We also performed similar immunoblots with ROCA2, a mAb 
generated in the same fusion, which binds to ganglia and inter- 
costal nerves from all rostra1 and caudal levels equally well. 
While ROCA2 does not specifically recognize any proteins in 
the detergent-insoluble fraction, it does strongly bind a 26 kDa 
protein in the detergent-soluble fraction (Fig. lb). This finding 
raised the possibility that ROCAl and ROCA2 recognize the 
same 26 kDa protein. To test this hypothesis we used ROCAl 
to immunoprecipitate the 26 kDa protein from 1% Triton X- 100 
extracts of sciatic nerve membrane/cytoskeletal preparations. 
Proteins specifically precipitated by ROCA 1 were separated by 
SDS-PAGE and transferred to nitrocellulose, and an immu- 
noblot analysis was then performed using ROCA2. ROCA2 
clearly recognizes the major 26 kDa protein that was immu- 
noprecipitated by ROCAl (Fig. 2). As described below, the 
higher-molecular-weight bands observed on this blot are prob- 
able glycosylation variants of the 26 kDa protein. 
Identijcation of the 60 kDa ROCAI antigen 
The Triton X-100 insolubility of the 60 kDa ROCAl antigen 
hampered immunoaffinity chromatography purification of this 
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Figure 3. Two-dimensional gel and immunoblot analysis of Triton X- 1 00-insoluble adult rat sciatic nerve proteins. A 1% Triton X- 1 OO-soluble 
sciatic nerve fraction, prepared as described in Materials and Methods, was subjected to isoelectric focusing in the horizontal dimension (0.2% 
ampholines, pH 4.5-5.4; Pharmalyte) @‘Farrell, 1975), followed by SDS-PAGE in the vertical dimension (10% acrylamide, 1.5 mm). Proteins 
were then transferred to nitrocellulose membranes. a, Coomassie blue stains several proteins in the transfer. b, ROCAl hybridoma supematant 
binds a single protein spot (small arrow) at 60 kDa and p1 5.0, in a similar transfer. The ROCAl-positive spot is also visualized by Coomassie 
blue staining (a, small arrow). The p1 was estimated from duplicate two-dimensional gels containing these protein standards: rat serum albumin 
(~15~4) and trypsin inhibitor (~14.6). The corresponding positions of these marker proteins are designated atthe bottom, in the horizontal dimension. 
Approximately 60 pg of total protein was loaded in each of the gels. Primary antibody binding was visualized with a peroxidase-conjugated goat 
anti-mouse IgG secondary antibody. 
protein. Therefore, we used two-dimensional gel electrophoresis 
(O’Farrell, 1975) for antigen purification. A Coomassie-stained 
nitrocellulose transfer of T&on-insoluble adult rat sciatic nerve 
proteins is shown in Figure 3a. On an identical transfer, ROCAl 
labels a single 60 kDa spot of protein that migrates with a p1 
of about 5.0 (Fig. 3b). The position of the ROCAl-immuno- 
reactive spot is indicated by an arrow on the transfer stained 
for total protein, where it is clear that the antigen represents a 
major T&on-insoluble component. Since the ROCAl spot was 
well separated from contaminating proteins, and was clearly 
detectable by Coomassie staining, it seemed likely that multiple, 
two-dimensional gel electrophoresis runs could be used to obtain 
significant amounts of the purified protein for amino acid se- 
quencing. 
The protein spot was excised from 52 Ponceau-S-stained ni- 
trocellulose transfers of Triton X- 1 OO-insoluble adult rat sciatic 
nerve proteins. The nitrocellulose pieces were then digested with 
trypsin. The resulting peptide fragments were separated by high- 
pressure liquid chromatography, and non-trypsin peaks were 
subjected to microsequencing by Edman degradation (Tempst 
et al., 1990). Four distinct sequences were obtained, each with 
striking similarity to sequences present in rat peripherin (Leon- 
ard et al., 1988). The sequences of these peptides and the cor- 
responding peripherin residues are aligned in Table 1. 
The identification of the 60 kDa ROCA 1 antigen as peripherin 
was further demonstrated in two ways. First, we compared the 
binding of ROCAl and an anti-peripherin antiserum to nitro- 
cellulose transfers of T&on-insoluble adult rat sciatic nerve 
proteins that had been separated by two-dimensional electro- 
phoresis. The anti-peripherin antiserum binds a spot in the same 
position as the ROCAl-immunoreactive 60 kDa protein (Fig. 
4). Second, we determined whether ROCAl binds recombinant 
peripherin on immunoblots. The peripherin fusion protein (ob- 
tained from L. Parysek) was generated from a nearly full-length 
peripherin cDNA insert containing coding sequence for all but 
the N-terminal 21 amino acids (56 kDa) (Leonard et al., 1988), 
plus a portion of the E. co/i trpE open reading frame (37 kDa). 
ROCA 1 binds the peripherin fusion protein that migrates with 
the expected size of 93 kDa (Fig. 5). This result also indicates 
that the ROCAl epitope is composed of amino acids, not car- 
bohydrate. 
Expression pattern of the ROCAl epitope on peripherin 
Consistent with the biochemical identification of the 60 kDa 
ROCAl antigen as peripherin, ROCAl labels the peripherin- 
positive subpopulation of neurons in sections of early postnatal 
DRG (Fig. 6a,b). The small-diameter neurons that strongly ex- 
press peripherin are identified using the anti-peripherin anti- 
serum on serial sections (Fig. 6b). As previously reported for 
adult sympathetic ganglia (Suzue et al., 1990), however, ROCAl 
does not label peripherin-positive neurons in sections of adult 
DRG (Fig. 6c,d). Instead, as in the adult sympathetic ganglia 
sections, ROCAl labeling appears to be localized outside and 
Table 1. Amino acid sequences derived from the 60 kDa ROCAl 
antigen and rat peripherin 
Peptide 1 
Peripherin E ml ‘D /:: i E 1 
Peptide 2 
Peripherin El E I::] i El 
Peripherin 2 m “D -1 
Peptide 3 
Peptide 4 
Peripherin 1 c ml z ml r 
Four peptides were generated from the 60 kDa ROCAl antigen and their amino 
acid sequences were determined as described in the Results and Materials and 
Methods. Common residues are enclosed by lines and printed in boldface. An X 
represents a residue whose identity could not be. unambiguously determined. 
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Figure 4. ROCAI and the anti-peripherin antiserum bind the same 
spot on two-dimensional immunoblots of a Triton X-100-insoluble 
fraction derived from adult rat sciatic nerves. Triton X-lOO-insoluble 
proteins were subjected to two-dimensional gel and immunoblot anal- 
ysis as described in the Figure 3 caption and Materials and Methods. 
The left panel shows the binding of ROCAl hybridoma supernatant to 
a single protein spot (large arrow) at 60 kDa and p1 5.0. The right panel 
shows the binding ofan anti-peripherin antiserum (199-2, diluted 1:2000), 
to a similar transfer. The peripherin antiserum binds a protein spot with 
the same coordinates as the 60 kDa ROCAl antigen. The location of 
pcripherin (large arrow), on these transfers, was indicated by a penciled- 
in arrow after transient Ponceau-S staining of the nitrocellulose, and 
prior to antibody incubations. Approximately 60 pg of total protein was 
loade&in each gel. Primary antibody binding was visualized with a 
peroxidase-conjugated goat anti-mouse IgG secondary antibody (left) 
or a peroxidase-conjugated goat anti-rabbit IgG secondary antibody 
(right). 
adjacent to the neurons, probably in the satellite (glial) cells of 
the DRG (Fig. 6~). Immunoblot analysis of membraneicyto- 
skeletal fractions derived from early postnatal and adult DRG 
with the anti-peripherin antiserum and ROCAl demonstrates 
the presence of peripherin, as well as the ROCAl epitope on 
peripherin in both young and mature DRG (data not shown). 
Thus, the ROCAl epitope on peripherin is, in fact, present in 
mature DRG and sympathetic neurons but is not immunohis- 
tochemically accessible. 
Previous immunoblot analysis demonstrated that the ROCA 1 
epitope on the 60 kDa protein is expressed in a rostrocaudal 
gradient in intercostal nerves (Suzue et al., 1990). Having iden- 
tified the 60 kDa ROCAl antigen as peripherin, we next asked 
whether the peripherin protein itself is also distributed in a 
rostrocaudal gradient using the anti-peripherin antiserum. 
Membrane/cytoskeletal fractions of adult rat intercostal nerves 
taken from segments T2-T12 were prepared as previously de- 
scribed (Suzue et al., 1990). Equal amounts of protein from each 
of the nerve preparations were separated by SDS-PAGE and 
transferred to nitrocellulose. To document the rostrocaudal dis- 
tribution of peripherin, an immunoblot analysis was then per- 
formed using ROCAl and the anti-peripherin antiserum. mAbs 
specific for NF-M and MBP were used as measures of neuronal 
cytoskeletal proteins and myelin, respectively. As previously 
reported (Suzue et al., 1990), the binding of ROCA 1 is highest 
in the rostra1 segments and declines in a graded manner in the 
more caudal segments relative to NF-M and MBP (Fig. 7). The 
rostr&audal difference between levels T2 + 3 and T 12 for ROCA 1 
binding, normalized to MBP or NF-M, is about fourfold (Fig. 
7). The binding of the anti-peripherin antiserum is also highest 
in the rostra1 segments. The rostrocaudal difference for the an- 
tiserum binding is not as pronounced as with ROCA 1, however; 
anti-peripherin antiserum binding, normalized to MBP or NF- 
M, is only about twofold greater for T2+3 than for T12 (Fig. 
7). The levels of MBP and NF-M show no obvious rostrocaudal 
106 kD= 
80 . 
Sc.N. Fus. 
-93 kD 
50 ’ 
-60 kD 
Figure 5. ROCAl binds recombinant peripherin. A peripherin fusion 
protein and Triton X-lOO-insoluble proteins derived from adult rat 
sciatic nerves were subjected to immunoblot analysis. ROCAl hybrid- 
oma supematant binds the 60 kDa native peripherin (left lane) and the 
93 kDa peripherin fusion protein (obtained from L. Parysek; see Ma- 
terials and Methods) (right lane). Approximately 60 pg of total protein 
was loaded in the left lane, and about 0.5 fig of the fusion protein was 
loaded in the right lane. Primary antibody binding was visualized with 
a peroxidase-conjugated goat anti-mouse secondary antibody. 
differences (Fig. 7). These results indicate that the peripherin 
protein is expressed at higher levels in extreme rostra1 versus 
extreme caudal intercostal nerves. Moreover, the rostrocaudal 
difference in ROCAl binding to a rostra1 intercostal nerve, T4, 
and the sciatic nerve, normalized to MBP and NF-M, is about 
sixfold, while it is about threefold for the anti-peripherin anti- 
serum (data not shown). 
Expression of the ROCAI and ROCAZ epitopes on the 26 kDa 
protein 
The ROCAl antigen, distributed in a dramatic rostrocaudal 
gradient as visualized by immunohistochemical labeling ofadult 
peripheral nerves and ganglia, is likely to be a surface membrane 
protein, not a neuronal cytoskeletal component (Suzue et al., 
1990). Thus, although peripherin displays rostrocaudal differ- 
ences, it cannot be the antigen visualized in sections of periph- 
eral nerves and ganglia. Moreover, the complete solubilization 
with 1% Triton X-100 of the 26 kDa protein antigen from 
membrane/cytoskeletal fractions of adult rat peripheral nerves 
is consistent with the 26 kDa protein being the antigen visualized 
in immunohistochemistry of adult nerves and ganglia. In ad- 
dition, we compared the tissue distribution ofthe 26 kDa protein 
determined by immunoblotting with the immunohistochemical 
distribution, and find an excellent correlation (Table 2). A key 
point is that ROCA 1 stains sections of adrenal chromaffin cells, 
epithelial cells in the esophagus, and myelin tracts in the cere- 
bellum, where the 26 kDa, but not the 60 kDa antigen, is found. 
Thus, the 26 kDa protein is very likely the membrane antigen 
visualized in sections of adult sympathetic ganglia and inter- 
costal nerves. 
We also analyzed the rostrocaudal distribution of the 26 kDa 
protein. Equal amounts of the membrane/cytoskeletal prepa- 
rations (derived from intercostal nerves T2+3 through T12) 
used to generate the immunoblot presented in Figure 7a were 
separated into Triton X- 1 OO-soluble and -insoluble compo- 
nents. Equivalent amounts of detergent-soluble protein from 
each of the nerve preparations were subjected to SDS-PAGE 
and transferred to nitrocellulose. Immunoblot analysis with 
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Figure 6. ROCAl labels the cytoplasm of peripherin-positive neurons in postnatal, but not adult DRG. a and b, Serial frozen sections of postnatal 
day 8 (P8) DRG were labeled with ROCAI and the anti-peripherin antiserum. Both antibodies strongly label the cytoplasm of small-diameter 
neurons (small arrows). ROCAl but not the anti-peripherin antiserum also labels glial cells in the center of the ganglion. c and d, A single frozen 
section of an adult DRG was double labeled with ROCAl and the anti-peripherin antiserum as described in Materials and Methods. ROCAl 
displays little or no labeling of neuronal cytoplasm, but strongly labels satellite cells enwrapping the neurons (c). The anti-peripherin antiserum, 
on the other hand, labels only neurons (d). Scale bars, 50 Km. 
ROCA 1 and ROCA2 fails to show significant rostrocaudal dif- 
ferences in the levels of the 26 kDa protein (Fig. 8). The result 
with ROCA2 is consistent with the lack of an immunohisto- 
chemical gradient of this epitope (Suzue et al., 1990). The ab- 
sence of a detectable rostrocaudal gradient of the ROCAl epi- 
tope on the 26 kDa protein is not, however, consistent with the 
immunohistochemical distribution of this epitope (Suzue et al., 
1990). Thus, it seems likely that the rostrocaudal gradient ob- 
served with ROCAl on tissue sections is not due to enhanced 
expression of the 26 kDa antigen in rostra1 nerves. As in the 
case for the immunohistochemical gradient of the 43 kDa pro- 
tein in the retina, the ROCA 1 gradient in intercostal nerves may 
be due to a preferential masking of the ROCA 1 epitope on this 
antigen in sections of caudal nerves. 
Ident$catlon of the 26 kDa protein 
ROCA 1 immunoaffinity chromatography was used to purify the 
26 kDa protein from extracts of adult rat sciatic nerve. Silver- 
stained gels of a small amount of the column eluate indicate the 
purity of the preparation (Fig. 9). In addition to the major 26 
kDa protein, minor bands migrating at 30 kDa and 24 kDa are 
also present. It is very likely that the latter two bands are related 
to the 26 kDa protein, as they are both detected by ROCA2 in 
immunoblots, and the size of the 30 kDa protein is reduced to 
26 kDa after ENDO-F digestion (data not shown). Large amounts 
of two independently purified preparations were separated by 
SDS-PAGE and transferred to Immobilon membranes. The 
Coomassie-stained 26 kDa bands were excised and subjected 
to microsequencing by Edman degradation. The following con- 
sensus N-terminal sequence was obtained: 
XVKGGIDEVFYLLF 
This sequence is very similar to that of the protein termed CD9 
isolated from human platelets (Higashihara et al., 1990; Bouch- 
eix et al., 1991; Lanza et al., 1991): 
PVKGGTKCIKYLLF 
The identity at each end of this sequence (underlined) suggests 
that the ROCA 26 kDa antigen is either the rat homolog of 
human CD9, or that it is a nervous system variant ofthis protein. 
We also obtained internal sequence information from this 
purified ROCAl antigen. Approximately 10 Kg of the ROCA l- 
affinity-purified 26 kDa protein was subjected to SDS-PAGE, 
transferred to nitrocellulose, and stained with Ponceau-S. The 
26 kDa band was then excised and exhaustively digested with 
trypsin. The resultingpeptide fragments were separated by HPLC, 
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Figure 7. Peripherin is expressed in a rostrocaudal gradient in adult rat intercostal nerves. Membrane/cytoskeletal fractions of adult rat intercostal 
nerves taken from various segmental levels were subjected to SDS-PAGE and transferred to nitrocellulose. The nitrocellulose transfers were then 
cut into three pieces representing different molecular weight ranges, and an immunoblot analysis was performed as described in Materials and 
and non-trypsin peaks were subjected to microsequencing by 
Edman degradation. The following internal amino acid se- 
quence was obtained: 
ELQEFY K 
Except for the second residue, this sequence is identical to one 
present immediately adjacent to a trypsin cleavage site in human 
CD9 (Bouchiex et al., 1991; Lanza et al., 1991): 
EVQEFY K 
This sequence further supports the probable identification of 
the ROCA 26 kDa protein as a CD9 homolog. 
Discussion 
In an effort to identify surface molecules that define position in 
the mammalian nervous system, we generated a mAb, ROCA 1, 
that defines two rostrocaudal gradients: (I) a 60 kDa ROCAl 
antigen that is expressed at higher levels in rostra1 than in caudal 
intercostal nerves, as detected by immunoblot analysis, and (2) 
a 26 kDa ROCAI antigen that is labeled more strongly in rostra1 
than in caudal glial cells, as detected immunohistochemically 
(Suzue et al., 1990). We show here that two structurally distinct 
antigens, the cytoskeletal protein pcripherin and a probable rat 
homolog of the leukocyte/platelet surface protein CD9, very 
likely share the ROCAI epitope. While peripherin is expressed 
in a shallow rostrocaudal gradient, it is the ROCAl cpitope on 
CD9, and not the protein itself, that is preferentially localized 
in rostra1 nerves and ganglia. We generated another antibody 
in the same fusion, ROCAZ, that labels the same cells in ganglia 
and nerves as ROCA 1, but not in a position-selective manner 
(Suzue ct al., 1990). Surprisingly, the rat CD9 homolog iden- 
tified here also bears the ROCAZ epitope. 
Peripherin 
Peripherin is a 57 kDa, type III, intermediate filament protein 
(Leonard et al., 1988; Parysek et al., 1988; Landon ct al., 1989). 
The size and Triton X-100 insolubility of the 60 kDa ROCAl 
antigen are consistent with it being the cytoskeletal component 
peripherin. Moreover, ROCA 1 stains peripheral but not central 
neurons in sections ofneonatal rat tissues. Three additional lines 
of evidence identify the 60 kDa ROCAI antigen as rat peri- 
pherin. First, four internal amino acid sequences derived from 
the purified protein (see Table 1) exhibit high homology with 
rat peripherin sequences (Leonard et al., 1988). Second, an an- 
tiserum specific for peripherin binds a single major protein that 
migrates at the same position as the ROCAl-immunoreactive 
spot in two-dimensional immunoblots of membrane/cytoskel- 
eta1 fractions derived from adult rat sciatic nerves. This further 
suggests that ROCAl binds the most abundant peripherin is- 
oform. Two alternatively spliced forms of peripherin are known 
to be expressed at much lower levels and migrate differently in 
t 
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Table 2. The tissue distribution of the 26 and 60 kDa proteins 
compared with ROCAl immunohistochemistry 
Immuno- 
histo- Immunoblot 
Tissue chemistry 26 kDa 60 kDa 
Adult 
Sciatic nerve ++ ++ ++ 
Intercostal nerve ++ ++ ++ 
SCG ++ ++ ++ 
DRG ++ ++ ++ 
Adrenal medulla ++ ++ - 
Esophagus ++ ++ - 
Cerebellum + + - 
Liver - - - 
Spinal cord - - - 
Skeletal muscle - - - 
Newborn 
Sciatic nerve + + + 
SCG + + + 
Triton-soluble and -insoluble fractions derived from various adult and neonatal 
rat tissues were prepared as described in Materials and Methods. Immunoblot 
analysis ofTriton-soluble and -insoluble fractions with RDCA 1 was used to screen 
for binding to the 26 kDa protein, and the 60 kDa protein, respectively. Cry- 
osextions were also generated from the same tissues and processed with ROCAI 
immunohistochemistry as described in Materials and Methods. The relative level 
of labeling of sections and the relative level of binding to the 26 kDa and 60 kDa 
proteins arc indicated qualitatively by -, no labeling of sections or band; +, light 
labeling; or + +, bright labeling. Without exception, the level oflabeling ofsections 
is reflected in the amount of the 26 kDa protein detected on immunoblots. SCG, 
superior cervical ganglion. 
two-dimensional SDS-PAGE than the major form (Landon et 
al., 1989). Third, ROCA I binds a bacteria1 fusion protein gen- 
erated from a peripherin cDNA. This further demonstrates that 
the ROCAl epitope is composed of amino acids and not car- 
bohydrate. 
The initial characterization of ROCAl binding by immu- 
noblot analysis suggested that the 60 kDa protein was prefer- 
entially expressed in rostra1 versus caudal intercostal nerves 
(Suzue et al., 1990). The enhanced binding of an antiserum 
specific for pcripherin to rostra1 nerves, on similar immuno- 
blots, supports this result. Although the difference in antiserum 
binding between extreme rostra1 and caudal levels is not as 
pronounced as with ROCA 1, both reagents can be used to define 
rostrocaudal position. This is further supported by the dcm- 
onstration that pcripherin levels, as determined by immunoblot 
analysis with ROCAl and the anti-peripherin antiserum, are 
higher in rostra1 intercostal nerves than in sciatic nerve. The 
present results extend those of Suzue et al. (1990) by showing 
that there is a rostrocaudal gradient of peripherin with respect 
to NF-M, as well as to MBP. This indicates that the binding of 
ROCA I and the anti-peripherin antiserum does not simply re- 
Methods. a. The fan oanel shows the bindina of anti-NF-M (I:2000 dilution) to the 160 kDa neurofilament (along with degradation products that 
migrate at siightly Ibier molecular weights),ihe middlepaneishows the binding of ROCAI hybridoma supematani to the 65 kDa peipherin (Per), 
and the boltom panel shows the binding of anti-MBP (I :500) to the 18.5 kDa and I4 kDa species of MBP present in these nerves. Equal amounts 
of protein (40 rg) were loaded in each lane. This immunoblot and five similar ones were scanned by laser densitometry. The plots show the mean 
ROCAI:MBP, ROCAI:NF-M, and NF-M:MBP ratios (set to 1.0 for pooled T2 and T3 segments) for each segment, with the corresponding SEM 
values. b, The fop panel shows the binding of anti-NF-M to the I60 kDa neurofilament, the middle panel shows the binding of the anti-peripherin 
antiserum to the 60 kDa peripherin, and the bottom panel shows the binding of anti-MBP to the two species of MBP present in these nerves. The 
same membrane/cytoskeletaI fractions (40 pg per lane) used in u were used to generate this immunoblot. This immmunoblot (which shows the 
most pronounced rostrocaudal difference of anti-pcriphcrin antiserum binding) and three others, also derived from fractions used in the analysis 
in a, were scanned by laser densitometry. The plots show the mean peripherin:MBP, peripherin:NF-M, and NF-M:MBP ratios (set to I .O for pooled 
T2 and T3 segments) for each segment, with the corresponding SEM values. 
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Figure 8. The 26 kDa protein is not expressed in a rostrocaudal gradient in adult rat intercostal nerves. Triton X-lOO-soluble fractions derived 
from equal amounts of the membrane/cytoskeletal preparations used in Figure 7a were subjected to SDS-PAGE and immunoblot analysis. As 
shown in Figure 7a, the original membrane/cytoskeletal preparations contain essentially equal amounts of MBP along the rostrocaudal axis. The 
top left panel shows the binding of ROCA 1 hybridoma supernatant to the 26 kDa protein, while the top right pane1 shows the binding of ROCAZ 
hybridoma supematant to the 26 kDa and minor, related proteins. Primary antibody binding was visualized with a peroxidase-conjugated goat 
anti-mouse secondary antibody. Approximately 40 pg of protein was loaded in each lane. The bottom left and right panels illustrate the results of 
densitometric scans of ROCAl and ROCA2 binding (normalized to the binding at level T2+3, which was set to 1.0) to the 26 kDa protein, 
respectively. Neither ROCA 1 nor ROCA2 binding reveals significant rostrocaudal differences in the expression ofthe 26 kDa protein. No rostrocaudal 
difference in binding to the 26 kDa protein was obvious even when significantly less protein was loaded in each lane, and an immunoblot performed 
with ROCAZ (data not shown). ROCAZ binding to the minor proteins also fails to show a positional difference. The results in the left panel are in 
dramatic contrast to the ROCAl immunohistochemical results showing a dramatic rostrocaudal gradient of labeling in sections of these same 
nerves (Suzue et al., 1990). 
fleet a rostrocaudal gradient of cytoskeletal versus myelin pro- 
tein expression. 
The finding that peripherin expression is enhanced in rostra1 
nerves extends results from other systems demonstrating po- 
sition-specific expression of peripherin and particular epitopes 
on NF-M. For example, transcripts of the Xenopus peripherin 
homolog XIF3 are enriched in the anterior over the posterior 
early embryonic nervous system (Sharpe et al., 1989). In the 
retinotectal system, a phosphorylated epitope on NF-M under- 
goes a complex temporal and spatial regulation during ganglion 
cell axon outgrowth and synapse formation (Go et al., 1989). 
Another recently characterized phosphorylated epitope on NF-M 
is expressed preferentially in the most distal portion of motor 
axons in the chick embryo. This epitope is labeled by a mAb 
at a particular time in development when each group of motor 
axons is known to respond to guidance cues that lead them to 
their appropriate muscles (Landmesser and Swain, 1992). These 
findings suggest that intermediate filament gene expression may 
be position specific as well as cell type specific. 
Unlike other type III family members (glial fibrillary acidic 
protein, desmin, and vimentin), peripherin is exclusively ex- 
pressed in neurons, and predominantly in the PNS (Portier et 
al., 1984; Leonard et al., 1988; Parysek and Goldman, 1988; 
Parysek et al., 1988; Escurat et al., 1990). In contrast to the type 
IV neurofilament triplet proteins, however, peripherin is not 
expressed in all peripheral neurons. Immunofluorescence la- 
beling of adult rat sciatic nerve sections with peripherin-specific 
antisera indicates that peripherin is enriched in small-caliber 
axons (Parysek et al., 199 1). Peripherin is also enriched in small- 
diameter DRG neurons (Parysek and Goldman, 1988; Escurat 
et al., 1990; Ferri et al., 1990; Goldstein et al., 1991). ROCAl 
also strongly labels the cytoplasm of small-diameter, peripherin- 
positive neurons in sections of DRG taken from early postnatal 
rats (Fig. 7a), but the intensity of this staining declines with 
development, so that ROCAl fails to label peripherin-positive 
neurons in sections taken from adult animals. We suggest hat 
the ROCAl epitope on peripherin is progressively masked in 
situ during development, apparently by a noncovalent inter- 
action with another molecule. It seems unlikely that a post- 
translational modification of the protein directly masks this ep- 
The Journal of Neuroscience, June 1993, K?(6) 2505 
itope since it is composed of amino acids, and ROCA 1 continues 
to bind the 60 kDa band on immunoblots of adult DRG pro- 
teins. 
Developmentally and spatially regulated epitope masking, po- 
tentially through protein-protein interactions, has been ob- 
served in other systems. For example, an immunohistochemical 
study has shown that antibody staining of the NILE protein is 
downregulated in maturing nerves, while Northern and im- 
munoblots demonstrate continued, high-level NILE expression 
into adulthood (Prince et al., 199 1). More relevant to the present 
study, a mAb (22/l@ that likely recognizes an intermediate 
filament protein specifically labels blastemal cells in sections of 
regenerating newt limbs, but reacts with a much wider range of 
tissues on immunoblots (Ferretti and Brockes, 1990). It is be- 
lieved that 22/ 18 detects a specific protein conformation that 
occurs transiently during regeneration and possibly during de- 
velopment (Ferretti and Brockes, 1990). In support of this, treat- 
ment of sections with the fixative ethylene glycol bissuccinimide 
(EGS), but not with paraformaldehyde, reveals the antigen in 
sections of normal and regenerating limbs in a distribution con- 
sistent with the one detected on the immunoblots (Ferretti and 
Brockes, 1990). Both fixatives cross-link proteins, but the re- 
active groups in EGS are spaced farther apart than those of 
paraformaldehyde. Interestingly, treatment of embryonic retina 
sections with EGS removes the pronounced dorsoventral asym- 
metry observed immunohistochemically on unfixed or parafor- 
maldehyde-fixed sections with a number of mAbs (see below; 
Rabacchi et al., 1990). 
26 kDdCD9 
Despite the compelling evidence that peripherin is a ROCAl 
antigen, immunohistochemical characterization of ROCA 1 
binding in sections of adult peripheral nerves and ganglia is 
inconsistent with the known distribution of peripherin. Most 
conspicuously, ROCA 1 stains glia - Schwann cells in nerves and 
satellite cells as well as Schwann cells in ganglia (Suzue et al., 
1990). In addition, ROCA 1 strongly labels myelin tracts in the 
cerebellum, chromaffin cells in the adrenal medulla, and a va- 
riety of epithelial cells (present results; S. Tole and P. H. Pat- 
terson, unpublished observations). The cell surface localization 
of the ROCAl epitope may also be inconsistent with peripherin 
being the antigen detected immunohistochemically (Suzue et 
al., 1990; Tole and Patterson, unpublished observations). On 
the other hand, the Triton X- 100 solubility of the 26 kDa ROCA 1 
antigen, and its tissue distribution as detected by immunoblot 
analysis strongly suggest that it is the protein detected immuno- 
histochemically in adult tissues. This ROCAl antigen was not 
present at sufficiently high concentrations in the membrane cy- 
toskeletal fractions to be detected along with peripherin in our 
previous analysis (Suzue et al., 1990). The fact that ROCAZ 
labels the same tissues and cell types as ROCAl, and that it 
binds the ROCA 1 -affinity-purified 26 kDa protein, further sup- 
ports the identification of this protein as the adult ROCA-glial 
surface antigen detected immunohistochemically. 
Based on N-terminal and internal amino acid sequence data 
from the affinity-purified 26 kDa protein, we have tentatively 
identified this ROCAl antigen as the rat homolog of human 
CD9. CD9 is a major transmembrane protein that has been 
recently purified from human platelets (Higashihara et al., 1990; 
Boucheix et al., 1991; Lanza et al., 1991) and whose primary 
structure has been elucidated by cDNA cloning (Boucheix et al., 
1991; Lanza et al., 1991). The human CD9 protein exists in 
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Figure 9. ROCAl immunoalhnity purification of the 26 kDa protein. 
A small amount of ROCAl-affinity-purified protein from adult rat pe- 
ripheral nerves (see Materials and Methods) was subjected to SDS- 
PAGE and silver staining. This purification yields a major protein at 
26 kDa and two minor components at 30 and 24 kDa. 
three forms ranging in molecular weight between 22 and 27 kDa 
(Kersey et al., 198 1; Newman et al., 1982; Boucheix et al., 1983; 
LeBien et al., 1985; Seehafer et al., 1988). This is consistent 
with ROCAl affinity column eluates containing three proteins 
with a similar molecular weight distribution. As in humans, the 
middle-molecular-weight form is the most abundant in rat, and 
the three forms are related, since ROCA2 binds each on im- 
munoblots (LeBien et al., 1985; data not shown). In addition, 
ROCAl and ROCAZ each bind a major 26 kDa Triton X- 1 OO- 
soluble protein in extracts of rat platelets (data not shown). 
These results all support the probable identification of the 26 
kDa ROCA antigen as a CD9 homolog. Interestingly, three 
N-terminal sequencing runs have yielded a consensus sequence 
with a string of five amino acids that does not match the cor- 
responding human CD9 residues. This may represent a rat- 
specific or a tissue-specific sequence. cDNA cloning of rat 
mRNAs should answer this question. 
Human CD9 is abundantly expressed on the surface of de- 
veloping B-lymphocytes, platelets, eosinophils, basophils, and 
stimulated T-lymphocytes, and has also been detected in a va- 
riety of nonhematopoietic tissues (Kersey et al., 198 1; Jones et 
al., 1982; Boucheix et al., 1987; Boucheix and Benoit, 1988; 
Von dem Borne et al., 1989). Two studies have used immu- 
nological methods to detect CD9 expression in certain human 
neuroblastoma cell lines (Kemshead et al., 1982; Komada et al., 
1983), but in vivo expression of CD9 in the nervous system has 
not been previously described. A number of perturbation studies 
have suggested a function for this molecule. mAbs against hu- 
man CD9 specifically induce homotypic adhesion of pre-B lym- 
phocytes (Masellis-Smith et al., 1990). In platelets, such anti- 
bodies induce activation and aggregation, leading to what is 
termed an adherent phenotype (Jennings et al., 1990; Griffith 
et al., 199 1). This activation also induces an association between 
CD9 and the GPIIb-IIIa integrin (Slupsky et al., 1989). That 
this CD9-integrin complex is involved in platelet aggregation 
is supported by the finding that platelets from patients with 
Glanzman’s thrombasthenia, which lack this integrin but not 
CD9, are not activated by anti-CD9 antibodies (Boucheix et al., 
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1983; Higashihara et al., 1985; Miller et al., 1986). In addition, 
anti-CD9 antibodies augment neutrophil adherence to endo- 
thelial cells, probably due to an adhesion-promoting activation 
event within the endothelial cell (Forsyth, 199 1). 
Taken together, these studies suggest a role for CD9 in the 
signaling involved in the adhesion and activation of blood cells 
mediated by intercellular cues. CD9 may participate in this 
function in association with molecules that directly mediate 
adhesion (e.g., integrins) (Slupsky ct al., 1989; Masellis-Smith 
et al., 1990; Forsyth, 199 1). It is logical to ask whether CD9 is 
involved in adhesion and signaling in the nervous system as 
well. In addition to Schwann cell surfaces, CD9 is expressed on 
neuronal surfaces (Tole and Patterson, unpublished observa- 
tions). Therefore, this protein could play a role in triggering or 
mediating homo- or heterotypic adhesion among Schwann cells 
and neurons. Since most mAbs specific for human CD9 arc 
directed against functional cpitopes (Boucheix and Benoit, 1988; 
Griffith et al., 199 l), we are currently using ROCA 1 and ROCAZ 
in in vitro perturbation studies. 
Gradients by dlxerential antigen expression and epitope 
masking 
ROCAl staining is highest in adult, rostra1 intercostal ncrvcs 
and declines in a graded manner in the caudal segments (Suzue 
et al., 1990). Nonetheless, ROCAl lab& the 26 kDa (CD9 
homolog) protein uniformly along the rostrocaudal axis on im- 
munoblots. We suggest, therefore, that the ROCAl epitope on 
CD9 is preferentially masked in situ in caudal nerves, probably 
as a result of a noncovalent interaction with another protein. 
The masking protein, which by analogy with the hematopoietic 
system could be an integrin, would thus be preferentially cx- 
prcsscd in the caudal nerves. In contrast to the results with 
ROCAl, the binding of ROCAZ to intercostal nerves detected 
immunohistochemically is consistent with the binding dctcctcd 
by immunoblot analysis. By either technique, ROCAZ binding 
does not reveal a rostrocaudal gradient ofCD9. The results with 
ROCAZ independently confirm that the CD9 protein itself is 
not prcfcrcntially expressed in rostra1 versus caudal nerves. This 
situation is analogous to that of the cxprcssion of a 43 kDa 
protein in the developing rat retina (McCaffery et al., 1990; 
Rabacchi et al., 1990). Multiple mAbs immunohistochemically 
detect a pronounced dorsoventral gradient, while the protein 
and corresponding mRNA are expressed at equivalent levels in 
dorsal and ventral retina halves. Thus, it is possible that epitopc 
masking can define position in the adult PNS, as well as in the 
developing retina. These results emphasize the unique ability 
of the mAb approach to detect positional differences that are 
not reflected in expression of the gene for the antigen. A sub- 
tractive hybridization cDNA approach, for example, would not 
have identified CD9 in a search for positional differences. 
It is striking that peripherin and CD9 each defne rostrocaudal 
position in the mammalian nervous system and also share the 
ROCAl epitope. Since peripherin is a cytoskeletal component 
and CD9 is a transmembrane protein, it seems unlikely that the 
shared epitope reflects a large degree of structural similarity 
between the two proteins. In fact, alignment of rat periphcrin 
and human CD9 protein sequences does not reveal any signif- 
icant stretches of identity. A definitive comparison will have to 
await acquisition of the entire rat sequence, however. 
A natural question raised by this study is what regulates the 
position-specific expression of pcripherin and the putative 
masking of CD9? One possibility is that periphcrin and the 
putative CD9-masking protein are downstream targets of HOX 
genes or analogous regulators of position. Interestingly, the per- 
ipherin promoter region contains an HOX 1.3 binding motif 
(F. Landon and M.-M. Portier, unpublished observations), and 
the chromosomal location of the mouse and human peripherin 
genes is very near the HOX 3.0 gene complex (Moncla et al., 
1992). In addition, as demonstrated by in situ hybridization, 
the expression of the HOX 1.1, I .2, 1.3, and 3. I genes is con- 
centrated in the thoracic region of mouse embryos (Holland and 
Hogan, 1988; Dressier and Gruss, 1989). All four genes arc 
expressed in mesoderm-related as well as ectoderm-derived tis- 
sues, such as the neural tube and spinal ganglia. Of particular 
intcrcst is the expression of HOX 3. I, which is restricted to 
caudal thoracic segments T6-TlO (Drcssler and Gruss, 1989). 
Since this region-specific pattern of expression persists in new- 
born mice, HOX 3.1 is a candidate for regulating the expression 
of proteins like the ones under study here. 
Note added in proof 
We have recently isolated several full-length cDNA clones using 
PCR with primers representing protein sequences derived from 
the purified 26 kDa protein and cDNA templatesgenerated from 
adult rat sciatic nerve and superior cervical ganglion RNA. These 
clones each display 90% identity (at the amino acid level) with 
human CD9, and each contain the same string of seven amino 
acids corresponding to one of the tryptic peptides generated from 
the purified 26 kDa protein, as well as these N-terminal 14 
amino acids: PVKGGSKCIKYLLF. The latter sequence is es- 
sentially identical to that found within human CD9, and quite 
similar to the N-terminal sequence derived from the purified 
26 kDa protein. The difference between the N-terminal sequence 
translated from the nucleotide sequence present in the cDNAs 
and that derived from the protein suggests that another, alter- 
natively spliced, form of CD9 may exist. These cloning data 
confirm that Cd9 is present in the rat nervous system, and 
support the identification of the 26 kDa antigen as CD9. 
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